|
Pfizer, Boehringer's Drug Helped to Delay Asthma Attacks
Bloomberg A lung drug from Boehringer Ingelheim GmbH and Pfizer Inc. (PFE) helped delay severe episodes in asthma patients, researchers said today in two studies that may result in broader use of the medicine. Spiriva, known chemically as tiotropium and … Boehringer's COPD drug shows promise in asthma COPD drug cuts asthma exacerbations First Phase III Data for Tiotropium in Symptomatic Asthma Patients Treated … |
View full post on asthma – Google News